| PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis H Boström, K Willetts, M Pekny, P Levéen, P Lindahl, H Hedstrand, ... Cell 85 (6), 863-873, 1996 | 1029 | 1996 |
| PDGF-C is a new protease-activated ligand for the PDGF α-receptor X Li, A Pontén, K Aase, L Karlsson, A Abramsson, M Uutela, G Bäckström, ... Nature cell biology 2 (5), 302-309, 2000 | 834 | 2000 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 546 | 2015 |
| Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial S Saussele, J Richter, J Guilhot, FX Gruber, H Hjorth-Hansen, A Almeida, ... The Lancet Oncology 19 (6), 747-757, 2018 | 542 | 2018 |
| A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general … AC Antoniou, X Wang, ZS Fredericksen, L McGuffog, R Tarrell, ... Nature genetics 42 (10), 885-892, 2010 | 406 | 2010 |
| Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia NCP Cross, HE White, D Colomer, H Ehrencrona, L Foroni, E Gottardi, ... Leukemia 29 (5), 999-1003, 2015 | 365 | 2015 |
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 351 | 2017 |
| Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families X Yang, G Leslie, A Doroszuk, S Schneider, J Allen, B Decker, ... Journal of clinical oncology 38 (7), 674, 2020 | 347 | 2020 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 329 | 2013 |
| Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers KB Kuchenbaecker, L McGuffog, D Barrowdale, A Lee, P Soucy, J Dennis, ... JNCI: Journal of the National Cancer Institute 109 (7), djw302, 2017 | 317 | 2017 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 306 | 2015 |
| Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ... Human mutation 39 (5), 593-620, 2018 | 288 | 2018 |
| A specific requirement for PDGF-C in palate formation and PDGFR-α signaling H Ding, X Wu, H Boström, I Kim, N Wong, B Tsoi, M O'Rourke, GY Koh, ... Nature genetics 36 (10), 1111-1116, 2004 | 284 | 2004 |
| Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low-or intermediate-risk chronic myeloid leukemia B Simonsson, T Gedde-Dahl, B Markevärn, K Remes, J Stentoft, ... Blood, The Journal of the American Society of Hematology 118 (12), 3228-3235, 2011 | 250 | 2011 |
| Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study M Baccarani, G Rosti, F Castagnetti, I Haznedaroglu, K Porkka, ... Blood, The Journal of the American Society of Hematology 113 (19), 4497-4504, 2009 | 249 | 2009 |
| Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia M Ilander, U Olsson-Strömberg, H Schlums, J Guilhot, O Brück, ... Leukemia 31 (5), 1108-1116, 2017 | 240 | 2017 |
| Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study J Staaf, D Glodzik, A Bosch, J Vallon-Christersson, C Reuterswärd, ... Nature medicine 25 (10), 1526-1533, 2019 | 228 | 2019 |
| Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA HE White, P Matejtschuk, P Rigsby, J Gabert, F Lin, Y Lynn Wang, ... Blood, The Journal of the American Society of Hematology 116 (22), e111-e117, 2010 | 185 | 2010 |
| Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits I Tachmazidou, D Süveges, JL Min, GRS Ritchie, J Steinberg, K Walter, ... The American Journal of Human Genetics 100 (6), 865-884, 2017 | 166 | 2017 |
| Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 AM Dunning, K Michailidou, KB Kuchenbaecker, D Thompson, JD French, ... Nature genetics 48 (4), 374-386, 2016 | 153 | 2016 |
